Incidence Patterns of Primary Bone Cancer in Taiwan (2003-010): A Population-Based Study

详细信息    查看全文

• 作者：Giun-Yi Hung MD (1) (2) (3)
  Jiun-Lin Horng PhD (4)
  Hsiu-Ju Yen MD (1) (2) (3)
  Chueh-Chuan Yen MD ; PhD (2) (3) (5)
  Wei-Ming Chen MD (2) (3) (6)
  Paul Chih-Hsueh Chen MD (2) (3) (7)
  Hung-Ta Hondar Wu MD (2) (3) (8)
  Hong-Jen Chiou MD (2) (3) (8) (9)
  
• 刊名：Annals of Surgical Oncology
• 出版年：2014
• 出版时间：August 2014
• 年：2014
• 卷：21
• 期：8
• 页码：2490-2498
• 全文大小：268 KB
• 参考文献：1. Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL. Cancer incidence among children and adolescents in the United States, 2001-003. / Pediatrics. 2008;121:e1470-7. CrossRef
  2. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. / Cancer. 2009;115:1531-3. CrossRef
  3. Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, et al. Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-005). / Cancer Epidemiol Biomarkers Prev. 2011;20:1770-7. CrossRef
  4. Guo W, Xu W, Huvos AG, Healey JH, Feng C. Comparative frequency of bone sarcomas among different racial groups. / Chin Med J ( / Engl). 1999;112:1101-.
  5. Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. / Int J Cancer. 2009;125:229-4. CrossRef
  6. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS. Taiwan cancer registry task force. Cancer trends in Taiwan. / Jpn J Clin Oncol. 2010;40:897-04. CrossRef
  7. Monthly bulletin of interior statistics [e-book]. 1.1 Number of villages, neighborhoods, households and resident population; 1.4 indigenous people. Available from http://sowf.moi.gov.tw/stat/month/elist.htm. Accessed 5 Apr 2013.
  8. Taiwan Cancer Registry annual report. Taiwan: health promotion administration, ministry of health and welfare. Available from http://www.hpa.gov.tw/Bhpnet/Web/Stat/StatisticsShow.aspx?No=200911300001. Accessed 5 Apr 2013.
  9. Percy C, Fritz A, Ries L. Conversion of neoplasms by topography and morphology, from the international classification of diseases for oncology, second edition to international classification of diseases for oncology, third edition. Cancer statistics branch, DCCPS, SEER program: National Cancer Institute, 2001. Available from http://seer.cancer.gov/tools/conversion/ICDO2-3manual.pdf. Accessed 18 Sep 2013.
  10. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration: principles and methods. Lyon: IARC Scientific Publications; 1991:126-8. Available from http://www.iarc.fr/en/publications/pdfs-online/epi/sp95/sp95-chap11.pdf. Accessed 2 Apr 2013.
  11. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. / Stat Med. 2000;19:335-1. CrossRef
  12. Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S, et al. Incidence and survival of malignant bone sarcomas in England 1979-007. / Int J Cancer. 2012;131:E508-7. CrossRef
  13. Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al; RARECARE working group. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. / Eur J Cancer. 2013;49:684-5. CrossRef
  14. Curado MP, Edwards B, Shin HR, Storm H, Feraly J, Heanue M, et al. Cancer incidence in five continents. Vol. IX. Lyon: IARC Scientific Publications; 2007:712-. Available from http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/. Accessed 6 Oct 2013.
  15. Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-005. / Cancer. 2009;115:3526-6. CrossRef
  16. Turcotte RE. Giant cell tumor of bone. / Orthop Clin North Am. 2006;37:35-1. CrossRef
  17. Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K. The epidemiology of malignant giant cell tumors of bone: an analysis of data from the surveillance, epidemiology and end results program (1975-004). / Rare Tumors. 2009;1:e52.
  18. Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, et al. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. / J Bone Joint Surg Am. 2012;94:461-. CrossRef
  19. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-995. / Cancer Causes Control. 2001;12:1-1. CrossRef
  20. Smoll NR, Gautschi OP, Radovanovic I, Schaller K, Weber DC. Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population. / Cancer. 2013;119:2029-7. CrossRef
  21. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. / Am J Public Health. 2006;96:252-1. CrossRef
  22. Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality: a review of recent evidence. / Autoimmun Rev. 2013;12:976-9. CrossRef
  23. Lee MS, Li HL, Hung TH, Chang HY, Yang FL, Wahlqvist ML. Vitamin D intake and its food sources in Taiwanese. / Asia Pac J Clin Nutr. 2008;7:397-07.
  24. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. / Epidemiol Rev. 1993;15:36-7.
  25. Schüler S, Ponnath M, Engel J, Ortmann O. Ovarian epithelial tumors and reproductive factors: a systematic review. / Arch Gynecol Obstet. 2013;287:1187-04. CrossRef
  26. Statistical yearbook of interior. 02-4 Fertility rates of childbearing age women. Available from http://sowf.moi.gov.tw/stat/year/list.htm. Accessed 5 Apr 2013.
  27. 2010 National Report of the Assisted Reproductive Technology Summary in Taiwan. Available from http://www.bhp.doh.gov.tw/BHPNet/English/file/ContentFile/201210020413361250/2010%20ART%20Report.pdf. Accessed 5 Apr 2013.
  28. Chen HY, Lin YH, Wu JC, et al. Characteristics of pediatric traditional Chinese medicine users in Taiwan: a nationwide cohort study. / Pediatrics. 2012;129:e1485-2. CrossRef
  29. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. / Public Health Nutr. 2004;7:187-00. CrossRef
  30. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. / J Natl Cancer Inst. 1981;66:1191-08.
  
• 作者单位：Giun-Yi Hung MD (1) (2) (3)
  Jiun-Lin Horng PhD (4)
  Hsiu-Ju Yen MD (1) (2) (3)
  Chueh-Chuan Yen MD, PhD (2) (3) (5)
  Wei-Ming Chen MD (2) (3) (6)
  Paul Chih-Hsueh Chen MD (2) (3) (7)
  Hung-Ta Hondar Wu MD (2) (3) (8)
  Hong-Jen Chiou MD (2) (3) (8) (9)
  
  1. Division of Pediatric Hematology and Oncology, Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
  2. Therapeutical and Research Center of Musculoskeletal Tumor, Taipei Veterans General Hospital, Taipei, Taiwan
  3. School of Medicine, National Yang-Ming University, Taipei, Taiwan
  4. Department of Anatomy, Taipei Medical University, Taipei, Taiwan
  5. Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  6. Departments of Orthopedics, Taipei Veterans General Hospital, Taipei, Taiwan
  7. Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan
  8. Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan
  9. National Defense Medical Center, Taipei, Taiwan
  
• ISSN：1534-4681

文摘

Background Primary bone cancer (BC) incidence by age has not been surveyed in Asia. Methods The incidence patterns of nine subtypes of primary BCs registered between 2003 and 2010 were analyzed from Taiwan cancer registry data. More specific analyses were conducted within age groups (Group I: 0-4?years; Group II: 25-9?years; and Group III: 60-5+ years). Results A total of 1,238 newly diagnosed subjects were registered with an age-standardized incidence rate (ASR) of 6.70 per million person-years. Overall, osteosarcoma (OS: 45?%) was the most common, followed by chondrosarcoma (CS: 18?%), and Ewing sarcoma (ES: 8?%). The percentages of cases and ASRs for age groups I, II, and III were 36.3, 43.0, and 20.7?%, and 7.00, 5.48, and 10.28 per million, respectively. Significant male predilections were observed for all BCs combined, and the CS, chordoma, and malignant ameloblastoma subtypes. Our findings demonstrated an upward trend of 4.8?% per year over the study period, and was more significant for females (6.7?%). A significant increase in trend existed in the incidence of BC among females in Group II, and the incidence of OS and ES among females in Group I. Conclusions This population-based study has allowed us to confidently define the incidence rates among three age groups of Taiwanese. Despite overall low rates, the upward trend in BC incidence among females may invoke a concern. The results suggest areas for further study into the underlying causes for these cancer trends.